Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Subclinical thyroid disorders--consequences and implications for treatment.

J A Franklyn1

  • 1Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK. j.a.franklyn@bham.ac.uk

Annales D'Endocrinologie
|July 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Triiodothyronine regulates angiogenic growth factor and cytokine secretion by isolated human decidual cells in a cell-type specific and gestational age-dependent manner.

Human reproduction (Oxford, England)·2014
Same author

Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumors.

The Journal of clinical endocrinology and metabolism·2013
Same author

Expression and function of thyroid hormone transporters in the microvillous plasma membrane of human term placental syncytiotrophoblast.

Endocrinology·2012
Same author

PTTG-binding factor (PBF) is a novel regulator of the thyroid hormone transporter MCT8.

Endocrinology·2012
Same author

The expression of thyroid hormone transporters in the human fetal cerebral cortex during early development and in N-Tera-2 neurodifferentiation.

The Journal of physiology·2011
Same author

Differential triiodothyronine responsiveness and transport by human cytotrophoblasts from normal and growth-restricted pregnancies.

The Journal of clinical endocrinology and metabolism·2010

Subclinical hyperthyroidism involves low thyroid-stimulating hormone (TSH) with normal thyroid hormones. Distinguishing between low-detectable and undetectable TSH levels is crucial for understanding its clinical significance.

Area of Science:

  • Endocrinology
  • Thyroid Disorders

Background:

  • Subclinical hyperthyroidism presents with low serum TSH and normal free T4/T3.
  • Subclinical hypothyroidism shows high serum TSH with normal free T4.
  • The clinical impact of low TSH may differ based on detectability.

Purpose of the Study:

  • To explore the clinical significance of low TSH values.
  • To differentiate the implications of detectable versus undetectable TSH.
  • To compare endogenous and exogenous causes of low TSH.

Main Methods:

  • Analysis of circulating TSH concentrations.
  • Assessment of free T4 and free T3 levels.
  • Comparison between endogenous and exogenous subclinical hyperthyroidism.

Related Experiment Videos

Main Results:

  • Low TSH characterizes subclinical hyperthyroidism.
  • Normal free T4 and T3 accompany low TSH.
  • High TSH indicates subclinical hypothyroidism.

Conclusions:

  • TSH levels are key indicators in subclinical thyroid dysfunction.
  • Further research is needed to clarify the significance of varying low TSH levels.